On Tuesday, the FDA announced that it will require the food industry to eliminate the use of artificial trans fats by 2018. Does that mean trans fats will soon disappear completely? Not quite. Here are five things to watch for as the FDA’s new ruling rolls out.
Leading journalists and a former Obamacare official offered predictions, discussed possible outcomes and shared story ideas for the much-anticipated Supreme Court decision on King v. Burwell at a Reporting on Health webinar this week.
With the explosion of public health data online, more journalists than ever need analytical tools in their daily work. Think of data as just another source to interview, along with people and documents.
Requiring certain ingredients to be listed on food labels can often drive larger changes in what we consume. The U.S. required trans fats to appear on food labels in 2006, but countries such as Brazil and Argentina have gone much further in setting limits on the unhealthy fats.
Why have policies limiting the prevalence of trans fats been so slow to arrive? A brief history explains how policy actions aimed at curbing such fats, now known for their role in chronic diseases, ultimately gained traction in tip-of-the-spear countries such as Denmark.
As teens age out of pediatric care, there's often a lag that can stretch on for years before they enter the fold of adult primary care. For young adults with chronic illnesses, that gap poses real risks. A recent study outlines the scope of the problem, even as progress on the issue remains stalled.
New projections estimate that Obamacare will add more than a quarter-billion dollars in administrative costs by 2022. About two thirds of this added expense will go to private insurance companies via the insurance exchanges. In contrast, public insurance gives far more bang for the buck.
Unhealthy trans fats have long remained a staple in our food supply, but that’s slowly starting to change. Denmark provides a useful case study for what happens when countries move to limit the amount of trans fats in food.
The privilege that has allowed parents to refuse immunizations for their kids stems not from economic or educational status — it springs from the privilege of not having seen the horrific diseases that ravaged U.S. children just two generations ago, and continue to do so worldwide.
Health insurers will often limit the size of provider networks to control costs, frustrating patients who suddenly find their doctor is now out-of-network. But do such "narrow networks" mean poorer quality care and access? Not necessarily, says a recent study of California plans.
